Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

NCCN Practice Guidelines for Prostate Cancer.

R R Bahnson1, G E Hanks, R P Huben

  • 1James Cancer Hospital and Solove Research Institute at Ohio State University, Columbus, Ohio, USA.

Oncology (Williston Park, N.Y.)
|February 24, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Validation of metastasis-free survival as a surrogate endpoint for overall survival in localized prostate cancer in the era of docetaxel for castration-resistant prostate cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2023
Same author

Clinical outcomes in men of diverse ethnic backgrounds with metastatic castration-resistant prostate cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2020
Same author

Patterns of relapse in poor-prognosis germ-cell tumours in the GETUG 13 trial: Implications for assessment of brain metastases.

European journal of cancer (Oxford, England : 1990)·2017
Same author

SU-E-T-567: Improve Dose Conformity with IMRT Using Shorter Source to Tumor Distance.

Medical physics·2017
Same author

Independent validation of the prognostic capacity of the ISUP prostate cancer grade grouping system for radiation treated patients with long-term follow-up.

Prostate cancer and prostatic diseases·2016
Same author

Positive Emotional Experience: Induced by Vibroacoustic Stimulation Using a Body Monochord in Patients with Psychosomatic Disorders: Is Associated with an Increase in EEG-Theta and a Decrease in EEG-Alpha Power.

Brain topography·2016
Same journal

Emerging T-Cell Engagers and Novel Immunotargets in Multiple Myeloma.

Oncology (Williston Park, N.Y.)·2026
Same journal

Access to Care and the Affordable Care Act: Why Do Problems Exist 15 Years Later?

Oncology (Williston Park, N.Y.)·2026
Same journal

Synchronous Endometrial and Ovarian Cancers: A Case Study and Literature Review.

Oncology (Williston Park, N.Y.)·2026
Same journal

Perceived Social Support, Anxiety, and Depression Among Women With Breast Cancer.

Oncology (Williston Park, N.Y.)·2026
Same journal

Before Certainty.

Oncology (Williston Park, N.Y.)·2026
Same journal

Adult T-Cell Leukemia/Lymphoma and Epstein-Barr Virus-Positive DLBCL: A Rare Concomitant Association.

Oncology (Williston Park, N.Y.)·2026
See all related articles

Systemic therapies and local treatments for prostate cancer are advancing, offering more options for high-risk and locally advanced cases. These evolving treatment guidelines promise improved outcomes for patients with prostate cancer.

Area of Science:

  • Oncology
  • Urology

Background:

  • Prostate cancer treatment landscape is evolving.
  • High-risk and locally advanced prostate cancer require advanced therapeutic strategies.

Framework:

  • Systemic therapies are poised for significant improvements.
  • Technical advancements in radiotherapy are expected.
  • Novel local modalities like cryoablation are emerging.

Implementation:

  • Improved systemic therapies will impact treatment protocols.
  • Enhanced radiotherapy and cryoablation offer expanded local control options.
  • Guidelines for prostate cancer management will continue to adapt.

Implications:

  • Future treatment of prostate cancer, particularly high-risk and locally advanced forms, will benefit from these advancements.

Related Experiment Videos

  • Increased therapeutic options will likely lead to better patient outcomes.
  • Continuous evolution of treatment guidelines is anticipated.